Navigation Links
MicroAire Surgical Instruments Acquires Endotine® (Formerly Owned by Coapt Systems)
Date:8/19/2010

CHARLOTTESVILLE, Va., Aug. 19 /PRNewswire/ -- MicroAire Surgical Instruments is pleased to announce the acquisition of Endotine® bioabsorbable, multi-point, soft-tissue fixation systems for facial aesthetic surgery. Endotine® is a patented system that allows surgeons to attach soft tissue to bone, or to other soft tissue -- using special tines instead of sutures -- thereby avoiding the tissue-strain associated with sutures.

Although Endotine® devices have the holding power of multiple sutures; the system actually has more in common with hook-and-loop systems, than with traditional needle and thread. This unique system allows surgeons to adjust the degree of lift during surgery. The additional strength from Endotine's® multiple fixation-points reduces tissue stretching and potential suture failure in a variety of facial procedures, including brow lifts, midface lifts, face lifts and neck lifts.

Endotine® is bioabsorbable, which means there are no secondary procedures required for implant removal. Endotine® devices hold tissue securely for three to four months and are then absorbed naturally, typically over a twelve-month period.  With seven years of clinical history, including excellent success rates in peer-reviewed publications, clinical trials showed virtually no issues of inflammation or adverse histologic response.

Customers and distributors of Endotine® devices will see no change in the availability of the products. MicroAire is planning to continue the product, invest in the product and grow the brand.

"Many surgeons already know that this is a fantastic product," said Alan Connor, MicroAire's Vice President of Operations. "We're ensuring that manufacturing and distribution processes remain the same, so that customers and distributors have full access to Endotine® products, as they always have. Same people, same location, same contact information. The only change for now will be the addition of the MicroAire logo, and our commitment to supporting and growing this product line."

MicroAire will continue to use the Coapt name on product packaging and some business documents during the period of product registration and transfer to MicroAire.

MicroAire Surgical Instruments, located in Charlottesville, Virginia, is a leading designer, manufacturer and distributor of surgical products in three key areas:  Orthopaedic Power Instruments, Endoscopic Soft-Tissue Release, and Aesthetic Plastic Surgery. MicroAire is a team, dedicated to enhancing quality of life by providing innovative surgical solutions that improve surgeon and patient outcomes. For more information, visit www.microaire.com.Donald J. Crotteau+1 434 975 8389dj.crotteau@microaire.com
'/>"/>

SOURCE MicroAire Surgical Instruments
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Innocoll Announces Dosing of First Patient in US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections in Cardiac Surgery Patients
2. Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-operative Pain
3. Portrait(R) Plasma - A New Non-Surgical Option for one of the Most Requested Aesthetic Treatment - Aging Eyes
4. New Non-Surgical Stem-Cell Procedure to Relieve Chronic Tendon Problems
5. Ceremeds OSTENE(R) Stops Bone Bleeding Without Added Risk of Surgical Infection, New Study Finds
6. Innocoll Announces Dosing of First Patient in Second US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections
7. Anesiva Commences Phase 3 Clinical Trial of Adlea(TM) for Reducing Post-Surgical Pain Following Bunionectomy
8. Anesiva Announces Pivotal Phase 3 Clinical Trial of Adlea(TM) for Reducing Post-Surgical Pain Following Total Knee Replacement
9. PEAK Surgical Announces Positive Results From Preclinical Study of PEAK PlasmaBlade(TM) for Obstetric and Gynecologic Surgery
10. Early Esophageal Cancer and Pre-Cancer Eliminated With Non-Surgical Treatment Combination
11. New Minimally Invasive Surgical Procedure Restores Quality of Life in Patients With Potentially Debilitating Spinal Condition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 24, 2016 Dehaier Medical Systems Ltd. (NASDAQ: ... develops, markets and sells medical devices and wearable sleep ... a strategic cooperation agreement with Hongyuan Supply Chain Management ... on June 20, 2016, to develop Dehaier,s new Internet ... agreement, Dehaier will leverage Hongyuan Supply Chain,s sales platform ...
(Date:6/24/2016)... Research and Markets has announced the addition of the ... to their offering. ... World Market for Companion Diagnostics covers the world market for ... report includes the following: , World IVD ... (N. America, EU, ROW), 2015-2020 , World IVD Companion ...
(Date:6/24/2016)... LEXINGTON, Mass. , June 24, 2016   ... specialty pharmaceutical company developing innovative inhaled drugs, announced today ... when Russell Investments reconstituted its comprehensive set ... 2016. "This is an important milestone for ... "It will increase shareholder awareness of our progress in ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... June 24, 2016 , ... The ... in Dallas that it will receive two significant new grants to support its ... PHA marked its 25th anniversary by recognizing patients, medical professionals and scientists for ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, CA is ... Road To Recovery® program to drive cancer patients to and from their cancer treatments. ... the highest quality of life and ongoing independence. Getting to and from medical ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB Medicine presented its ... Emergency Medicine conference in Ponte Vedra Beach, FL. The awards honor the outstanding ... Medicine Practice and Pediatric Emergency Medicine Practice. , “With this award, we ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... actively feeding the Frederick area economy by obtaining investment capital for emerging technology ... past 2½ years that have already resulted in more than a million dollars ...
(Date:6/24/2016)... MD (PRWEB) , ... June 24, 2016 , ... ... protocols for human induced pluripotent stem (iPS) cells and other difficult to transfect ... G9™ Cloning Medium. The PluriQ™ G9™ Gene Editing System is a ...
Breaking Medicine News(10 mins):